LUCAT1 and laryngotracheoesophageal cleft: Thus, MALAT1, LUCAT1, and TUG1 are associated with the survival of patients with LC; HOTAIR can serve as a biomarker of tumour progression; and NEAT1 is related to poor prognosis.